Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Slideshows|October 12, 2016
Politics Govern Treatment and More Medical News
Author(s)Leo Robert
Do doctors’ politics affect treatment decisions on, for example, drug use, firearms, and sexual behavior? Do yours?
Advertisement
Politics driving treatment decisions, a depression epidemic, cardiovascular risk with statins vs nonstatins-we offer these and other highlights of recent clinical studies of interest to primary care physicians.Scroll through the slides above for key findings. Original sources are below.
References:
Advertisement
Related to this article
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women
TMS 2026: A meta-analysis of 5 studies found hormone therapy linked to more frequent migraine attacks and migraine days, but not greater severity or analgesic use.
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Clears 15-Minute Blood Test to Help Distinguish Bacterial From Viral Infections
2
4 FDA Decisions for Primary Care to Know from October 2026
3
The Future of HIV PrEP and One Step to Take Tomorrow
4
Why a Negative Endometrial Biopsy May Not End the Abnormal Bleeding Workup
5